Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2007; 13(42): 5648-5653
Published online Nov 14, 2007. doi: 10.3748/wjg.v13.i42.5648
Published online Nov 14, 2007. doi: 10.3748/wjg.v13.i42.5648
Figure 1 Incidence of ascites or encephalopathy or gastrointestinal haemorrhage from the beginning of the first treatment according to the response to antiviral treatment (SVR: Sustained virological response in dotted line; non-SVR in full line; Log-Rank, P = 0.
44).
Figure 2 Incidence of hepatocellular carcinoma from the beginning of the first treatment according to response to antiviral treatment.
SVR: Sustained virological response in dotted line; Non-SVR in full line; Log-Rank, P = 0.01.
Figure 3 Incidence of death from the beginning of the first treatment according to response to antiviral treatment.
SVR: Sustained virological response in dotted line; Non-SVR in full line; Log-Rank, P = 0.002.
- Citation: Braks RE, Ganne-Carrié N, Fontaine H, Paries J, Grando-Lemaire V, Beaugrand M, Pol S, Trinchet JC. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin. World J Gastroenterol 2007; 13(42): 5648-5653
- URL: https://www.wjgnet.com/1007-9327/full/v13/i42/5648.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i42.5648